{"disease":{"id":"atrophic-vaginitis","name":"Atrophic vaginitis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":11,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"norethisterone","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"estradiol","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estrace","generic_name":"ESTRADIOL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":10,"revenue":null,"mechanism":"Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen."},{"drug_id":"estradiol-acetate","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Femring","generic_name":"ESTRADIOL ACETATE","company_name":"Apil","drug_phase":"marketed","molecular_target":"estrogen receptors","drug_class":"Estrogen","quality_score":55,"revenue":null,"mechanism":"Estrogens, primarily estradiol, bind to nuclear receptors in estrogen-responsive tissues, modulating the female reproductive system and reducing postmenopausal gonadotropin levels."},{"drug_id":"medroxyprogesterone","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Depo-Provera","generic_name":"medroxyprogesterone","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":null,"revenue":null,"mechanism":"Depo-Provera works by binding to the progesterone receptor in the body, which helps to regulate the menstrual cycle and prevent pregnancy."},{"drug_id":"estrone-sulphate","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ogen .625","generic_name":"estrone sulphate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Steryl-sulfatase","drug_class":"estropipate","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"endometrin","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Endometrin","generic_name":"progesterone","company_name":"Ferring","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"Progesterone [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"dienestrol","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Synestrol","generic_name":"DIENESTROL","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"dienestrol","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"ethinylestradiol","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ortho-Novum 10/11-21","generic_name":"Ethinylestradiol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"estring","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estring","generic_name":"Estradiol","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Ovulation","drug_class":"Combined Oral Contraceptive (COC)","quality_score":71,"revenue":null,"mechanism":"Prevents pregnancy primarily by suppressing ovulation."},{"drug_id":"drospirenone","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Slynd","generic_name":"DROSPIRENONE","company_name":"Exeltis Usa Inc","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"Progestin","quality_score":75,"revenue":null,"mechanism":"Slynd works by binding to the mineralocorticoid receptor, a protein that plays a role in hormone regulation."},{"drug_id":"progesteron","indication_name":"Atrophic vaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Progesteron","company_name":"Minia University","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":11,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03294538","title":"Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":663,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT04219605","title":"Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":226,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT06808347","title":"Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal Women","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Walter Reed National Military Medical Center","has_results":false},{"nct_id":"NCT04579991","title":"Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Chulalongkorn University","has_results":false},{"nct_id":"NCT06978907","title":"Evaluation of the Efficacy and Safety of Lactobacillus Crispatus M247 (Crispact®) With Vaginal Laser Therapy in Menopausal Women With Atrophic Vulvovaginitis (VVA)","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Liaquat University of Medical & Health Sciences","has_results":false},{"nct_id":"NCT04247022","title":"Evaluation of Gynecological Acceptability of a Health Care Product","phase":"NA","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Herbarium Laboratorio Botanico Ltda","has_results":false},{"nct_id":"NCT04327947","title":"Evaluation of Gynecological Acceptability of 3 Health Care Products","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Herbarium Laboratorio Botanico Ltda","has_results":false},{"nct_id":"NCT04079218","title":"Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Kerry Murphy","has_results":true},{"nct_id":"NCT05396261","title":"a Flexible Wound Dressing for the Management of Genital Skin Conditions","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Stratpharma AG","has_results":false},{"nct_id":"NCT06176820","title":"Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":52,"lead_sponsor_name":"Sarawak General Hospital","has_results":false},{"nct_id":"NCT00984399","title":"Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT03996603","title":"Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT05058313","title":"Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT05432154","title":"An Innovative Silicone Wound Dressing for the Management of Atrophic Vaginitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Stratpharma AG","has_results":false}],"total":14},"guidelines":[{"drug_id":"estring","guideline_body":"FDA label","recommendation":"Estring (estradiol) is indicated for the treatment of atrophic vaginitis.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"estring","guideline_body":"FDA label","recommendation":"Estring (estradiol) is indicated for the treatment of atrophic changes of the vulva.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"estring","guideline_body":"FDA label","recommendation":"Estring (estradiol) is indicated for the treatment of female hypogonadism syndrome.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"estring","guideline_body":"FDA label","recommendation":"Estring (estradiol) is indicated for the treatment of menopausal flushing.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}